China Medical System Holdings Limited
CHSYF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $16,489,192 | $26,451,797 | $23,356,937 | $26,647,594 |
| - Cash | $3,706,501 | $4,311,058 | $4,376,376 | $3,385,739 |
| + Debt | $860,743 | $1,301,737 | $1,812,632 | $1,712,305 |
| Enterprise Value | $13,643,434 | $23,442,476 | $20,793,193 | $24,974,160 |
| Revenue | $7,468,990 | $8,013,285 | $9,150,347 | $8,337,221 |
| % Growth | -6.8% | -12.4% | 9.8% | – |
| Gross Profit | $5,422,194 | $6,075,951 | $7,035,847 | $6,246,938 |
| % Margin | 72.6% | 75.8% | 76.9% | 74.9% |
| EBITDA | $2,308,155 | $2,922,149 | $3,761,571 | $3,704,679 |
| % Margin | 30.9% | 36.5% | 41.1% | 44.4% |
| Net Income | $1,619,788 | $2,400,940 | $3,258,992 | $3,017,402 |
| % Margin | 21.7% | 30% | 35.6% | 36.2% |
| EPS Diluted | 0.67 | 0.98 | 1.33 | 1.22 |
| % Growth | -31.6% | -26.3% | 9% | – |
| Operating Cash Flow | $1,268,547 | $2,502,853 | $3,553,243 | $2,493,852 |
| Capital Expenditures | -$455,908 | -$317,960 | -$524,921 | -$184,841 |
| Free Cash Flow | $812,639 | $2,184,893 | $3,028,322 | $2,309,011 |